Mogelijk gemaakt door Google TranslateTranslate
Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren
Latest Press Releases
View all
TimeHeadline
11m agoePlus Announces Fourth Quarter and Fiscal Year 2026 Earnings Release Date and Conference Call
11m agoAbbVie Announces New Data at ASCO 2026 Demonstrating Breadth and Momentum Across its Next-Generation Oncology Pipeline
11m agoCredissential Announces Private Placement
11m agoBTV Highlights Clinch Resources as First New U.S. Metallurgical Coal Producer to IPO in Eight Years, Nearing Production in West Virginia
37m agoSTL announces US Conec certification to offer MMC pre-terminated solutions for AI-Data Center deployments
Mankind Pharma Ltd. logo

Mankind Pharma Ltd.

About

2,514.10INR-69.80 -2.70%
Live at 23:12 GMT+00:00
Market Cap$11.04B
P/E Ratio54.32
Volume1.81M
Beta0.29
RSI66.76
Gross Margin43.11%
Health TechnologyPharmaceuticals: Major

Mankind Pharma Ltd. — investor relations, events, news, and company updates on 6ix.

Latest News

May 7 2026
Theravance Biopharma, Inc. Reports First Quarter 2026 Financial Results and Provides Corporate Update
Mar 18 2026
Press Release Mar 18 2026
Feb 3 2026
Press Release Feb 03 2026
Nov 21 2025
Actimed Therapeutics Announces Important Licensing Agreement with Mankind Pharma
Nov 6 2025
Press Release Nov 06 2025

Community Chat

Ask AI

6ix6ix